Recent Publications
1.Gamiotea-Turro D, Cronin CC, Liang BT, Verma R. Transcriptomic analysis reveals novel age-independent immunomodulatory proteins as a mode of cerebroprotection in P2X4 receptor knockout mice after ischemic stroke. Purinergic Signal. 2023 Jul 13. doi: 10.1007/s11302-023-09956-9. Epub ahead of print. PMID: 37439999.
2. Paro MR, Chakraborty AR, Angelo S, Nambiar S, Bulsara KR, Verma R. Molecular mediators of angiogenesis and neurogenesis after ischemic stroke. Rev Neurosci. 2023 Jun 27;34(4):425-442. doi: 10.1515/revneuro-2022-0049. Print 2023 Jun 27. PubMed PMID: 36073599.
3. Toti KS, Verma R, McGonnigle MJ, Gamiotea Turro D, Wen Z, Lewicki SA, Liang BT, Jacobson KA. Structure-Activity Relationship and Neuroprotective Activity of 1,5-Dihydro-2H-naphtho[1,2-b][1,4]diazepine-2,4(3H)-diones as P2X4 Receptor Antagonists. J Med Chem. 2022 Oct 27;65(20):13967-13987. doi: 10.1021/acs.jmedchem.2c01197. Epub 2022 Sep 23. PubMed PMID: 36150180; PubMed Central PMCID: PMC9653265.
4. Dhuri K, Vyas R, Blumenfeld L, Verma R, Bahal R. Nanoparticle Delivered Anti-miR-141-3p for Stroke Therapy. Cells 2021, 10(5), 1011; https://doi.org/10.3390/cells10051011 5. Srivastava P, Cronin CG, Scranton VL, Jacobson KA, Liang BT, Verma R*. Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic stroke. Exp Neurol. 2020 Jul; 329:113308. doi: 10.1016/j.expneurol.2020.113308. Epub 2020 Apr 11. PubMed PMID: 32289314; PubMed Central PMCID: PMC7242087.
6.Patrizz A, Doran SJ, Chauhan A, Ahnstedt H, Roy-O'Reilly M, Lai YJ, Weston G, Tarabishy S, Patel AR, Verma R, Staff I, Kofler JK, Li J, Liu F, Ritzel RM, McCullough LD. EMMPRIN/CD147 plays a detrimental role in clinical and experimental ischemic stroke. Aging (Albany NY). 2020 Mar 19;12(6):5121-5139. doi: 10.18632/aging.102935. Epub 2020 Mar 19. PubMed PMID: 32191628; PubMed Central PMCID: PMC7138568.
7.Ritzel RM, Al Mamun A, Crapser J, Verma R, Patel AR, Knight BE, Harris N, Mancini N, Roy-O'Reilly M, Ganesh BP, Liu F, McCullough LD. CD200-CD200R1 inhibitory signaling prevents spontaneous bacterial infection and promotes resolution of neuroinflammation and recovery after stroke. J Neuroinflammation. 2019 Feb 18;16(1):40. doi: 10.1186/s12974-019-1426-3. PubMed PMID: 30777093; PubMed Central PMCID: PMC6378746
8. Verma R, Ritzel RM, Harris NM, Lee J, Kim T, Pandi G, Vemuganti R, McCullough LD. Inhibition of miR-141-3p Ameliorates the Negative Effects of Poststroke Social Isolation in Aged Mice. Stroke. 2018 Jul;49(7):1701-1707. doi: 10.1161/STROKEAHA.118.020627. Epub 2018 Jun 4. PubMed PMID: 29866755; PubMed Central PMCID: PMC6019570.